In vitro activities in new oxazolidinone antimicrobial agents against enterococci
- 1 July 1996
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 40 (7) , 1745-1747
- https://doi.org/10.1128/aac.40.7.1745
Abstract
The comparative in vitro activities of two new oxazolidinone antimicrobial agents, U-100592 and U-100766, against 180 isolates of enterococci representing several resistance profiles were examined by using an agar dilution technique. The two oxazolidinones inhibited all isolates, including strains resistant to vancomycin, ampicillin, and minocycline, at concentrations between 1 and 4 micrograms/ml.Keywords
This publication has 10 references indexed in Scilit:
- In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsAntimicrobial Agents and Chemotherapy, 1996
- In vitro activities of two glycylcyclines against gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1994
- A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococciAntimicrobial Agents and Chemotherapy, 1993
- Genetics and mechanisms of glycopeptide resistance in enterococciAntimicrobial Agents and Chemotherapy, 1993
- In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organismsAntimicrobial Agents and Chemotherapy, 1993
- Emergence of Enterococcus as a Significant PathogenClinical Infectious Diseases, 1992
- Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228Antimicrobial Agents and Chemotherapy, 1990
- Identification of Enterococcus species isolated from human infections by a conventional test schemeJournal of Clinical Microbiology, 1989
- Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compoundAntimicrobial Agents and Chemotherapy, 1988
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJournal of Antimicrobial Chemotherapy, 1988